Free Trial

Pro-Dex (PDEX) Competitors

Pro-Dex logo
$44.35 +0.02 (+0.05%)
Closing price 01/17/2025 04:00 PM Eastern
Extended Trading
$44.08 -0.27 (-0.60%)
As of 08:45 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PDEX vs. KIDS, TMCI, SMLR, NNOX, CLPT, TCMD, DCTH, ZIMV, CVRX, and NPCE

Should you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), Nano-X Imaging (NNOX), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Delcath Systems (DCTH), ZimVie (ZIMV), CVRx (CVRX), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry.

Pro-Dex vs.

Pro-Dex (NASDAQ:PDEX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends, community ranking and analyst recommendations.

Pro-Dex has a net margin of 9.17% compared to OrthoPediatrics' net margin of -15.00%. Pro-Dex's return on equity of 16.74% beat OrthoPediatrics' return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex9.17% 16.74% 9.98%
OrthoPediatrics -15.00%-5.78%-4.80%

Pro-Dex presently has a consensus target price of $52.00, indicating a potential upside of 17.25%. OrthoPediatrics has a consensus target price of $39.00, indicating a potential upside of 43.59%. Given OrthoPediatrics' higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Pro-Dex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
OrthoPediatrics
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Pro-Dex has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$53.84M2.69$2.13M$1.5428.80
OrthoPediatrics$148.73M4.42-$20.97M-$1.23-22.08

In the previous week, Pro-Dex had 8 more articles in the media than OrthoPediatrics. MarketBeat recorded 12 mentions for Pro-Dex and 4 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.52 beat Pro-Dex's score of 0.40 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pro-Dex
7 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
OrthoPediatrics
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

OrthoPediatrics received 157 more outperform votes than Pro-Dex when rated by MarketBeat users. Likewise, 64.26% of users gave OrthoPediatrics an outperform vote while only 61.85% of users gave Pro-Dex an outperform vote.

CompanyUnderperformOutperform
Pro-DexOutperform Votes
154
61.85%
Underperform Votes
95
38.15%
OrthoPediatricsOutperform Votes
311
64.26%
Underperform Votes
173
35.74%

Pro-Dex has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500.

Summary

OrthoPediatrics beats Pro-Dex on 9 of the 17 factors compared between the two stocks.

Get Pro-Dex News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDEX vs. The Competition

MetricPro-DexSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$144.55M$4.78B$5.34B$9.11B
Dividend YieldN/A52.58%5.37%4.00%
P/E Ratio28.8013.8156.8413.06
Price / Sales2.6958.081,275.3476.04
Price / Cash46.3150.8936.6132.89
Price / Book4.917.794.874.58
Net Income$2.13M$13.87M$118.05M$224.84M
7 Day Performance-1.44%2.85%1.47%2.37%
1 Month Performance-9.01%10.48%2.54%4.40%
1 Year Performance109.99%32.32%25.37%20.10%

Pro-Dex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDEX
Pro-Dex
3.4622 of 5 stars
$44.35
+0.0%
$52.00
+17.2%
+110.0%$144.55M$53.84M28.80140
KIDS
OrthoPediatrics
4.0311 of 5 stars
$25.00
+2.3%
$39.00
+56.0%
-5.8%$605.40M$189.67M-20.33200Short Interest ↑
TMCI
Treace Medical Concepts
0.8977 of 5 stars
$8.36
+14.5%
$8.98
+7.5%
-32.6%$520.80M$202.86M-8.44250
SMLR
Semler Scientific
1.1592 of 5 stars
$52.70
+2.6%
N/A+47.8%$488.37M$58.94M25.71120Gap Up
NNOX
Nano-X Imaging
2.367 of 5 stars
$7.39
-8.4%
$17.50
+136.8%
+56.9%$426.99M$10.68M-8.69190Gap Down
CLPT
ClearPoint Neuro
0.6185 of 5 stars
$15.40
+4.9%
$11.33
-26.4%
+100.3%$424.81M$30.43M-22.32110Positive News
TCMD
Tactile Systems Technology
3.5201 of 5 stars
$17.20
-0.2%
$23.00
+33.7%
+27.5%$412.75M$285.05M26.46980
DCTH
Delcath Systems
3.5967 of 5 stars
$12.79
+11.4%
$21.50
+68.1%
+261.4%$408.90M$2.07M-9.4760Gap Up
ZIMV
ZimVie
2.9337 of 5 stars
$13.64
+1.1%
$19.50
+43.0%
-19.8%$376.45M$451.29M-1.042,700News Coverage
Positive News
CVRX
CVRx
2.166 of 5 stars
$15.04
+6.1%
$16.67
+10.8%
-33.6%$364.93M$47.26M-5.57160News Coverage
Positive News
NPCE
NeuroPace
3.4117 of 5 stars
$12.11
+1.4%
$15.00
+23.9%
-16.2%$361.46M$76.45M-12.11170Analyst Forecast
News Coverage

Related Companies and Tools


This page (NASDAQ:PDEX) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners